Results 181 to 190 of about 56,684 (289)

Impact of C reactive protein on effectiveness of interleukin-17 and tumour necrosis factor inhibitors in axial spondyloarthritis: a Danish nationwide observational study. [PDF]

RMD Open
Høegh Pedersen A, Jensen KY, Hetland ML, Glintborg B.   +3 more
europepmc   +1 more source

Impact of Spondyloarthritis on Pregnancy Outcome: A Descriptive Analysis from a Specialized Center in Qatar

Samar Al Emadi,1 Nawal Nouman Hadwan,1 Rawan Saleh,1 Eman Satti,1 Rajvir Singh2 1Department of Rheumatology, Hamad Medical Corporation, Doha, Qatar; 2Medical Research Center, Statistics, Hamad Medical Corporation, Doha, QatarCorrespondence: Samar Al ...
Al Emadi S, Satti E, Singh R, Hadwan NN, Saleh R   +4 more
core  

Intestinal tuberculosis Mimicking Crohn's Disease with concomitant axial spondyloarthritis: A diagnostic and therapeutic challenge. [PDF]

IDCases
Muqsita V, Awalia, Amifta RN.
europepmc   +1 more source

Patients with poorer health status are more likely to have difficult-to-manage axial spondyloarthritis: insights from a real-world cohort. [PDF]

Ther Adv Musculoskelet Dis
Guła Z, Wilk M, Kuszmiersz P, Strach M, Korkosz M.   +4 more
europepmc   +1 more source

Doppler ultrasound - a valid and reliable tool to assess spondyloarthritis

, 2012
Enthesitis is the hallmark of spondyloarthritis and is observed in all subtypes. Namely, a wide information on spondyloarthritis abnormalities, including synovitis, bursitis, tendinitis, enthesitis and cortical bone abnormalities (erosions and ...
De Miguel, Eugenio, Falcão, Sandra, Castillo,  Concepcion, Branco, Jaime, Martin-Mola,  Emilio   +4 more
core  

Associations of muscle mass, adipose tissue mass, and skeletal muscle radiodensity with disease activity in axial spondyloarthritis. [PDF]

Ther Adv Musculoskelet Dis
Cui R, Song XY, Wei JY, Zhou WL, Tao YL, Wei XE, Chen Z, Dai SM.   +7 more
europepmc   +1 more source

Representation of underserved communities in non-pharmacological axial spondyloarthritis trials: a scoping review protocol. [PDF]

Rheumatol Adv Pract
Mathew A, Prior Y, Buckley J, Loades J, Prior JA, Packham J, Battista S.   +6 more
europepmc   +1 more source

No major effect of age (< 40 vs. ≥ 40 years) on response to secukinumab in patients with axSpA: a post hoc analysis of six phase 3 trials. [PDF]

Arthritis Res Ther
Ramiro S, Gaillez C, Kiltz U, Gensler LS, Pisal C, Braun J, Ogdie A.   +6 more
europepmc   +1 more source

Faculty Opinions recommendation of 2019 update of the american college of rheumatology/spondylitis association of america/spondyloarthritis research and treatment network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature, 2020
P. Machado
semanticscholar   +1 more source

Efficacy and safety of dual-targeted therapy with tofacitinib and TNF inhibitors in refractory spondyloarthritis: a case series from a tertiary care center. [PDF]

Ther Adv Musculoskelet Dis
Agrawal A, Yadav SS, Balakrishnan C.
europepmc   +1 more source